Comera Life Sciences Holdings Inc Asset Turnover Ratio (CMRA), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Comera Life Sciences Holdings Inc   (NASDAQ: CMRA)
 

Comera Life Sciences Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Comera Life Sciences Holdings Inc asset turnover ratio, the ability of Comera Life Sciences Holdings Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 0.33 in the third quarter (Sep 30 2023), yet the ratio remained below the average, as CMRA's position remain challenging.

Within sector 40 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2023, to 963, from total ranking in the second quarter 2023 at 1833.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CMRA Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -37.78 % -61.83 % -59.09 % 330.18 % -
Y / Y Revenue Change -41.98 % 114.72 % 312.29 % -3.09 % 167.56 %
Asset Turnover Ratio (TTM) 0.33 0.31 0.21 0.11 0.13
CMRA's Total Ranking # 963 # 1833 # 783 # 0 # 0
Seq. Asset Change 31.27 % -21.97 % -19.53 % -24.51 % -19.47 %
Seq. Revenue Change -56.73 % -19.82 % 151.67 % -33.54 % 60.11 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 41
Healthcare Sector # 96
Overall Market # 963

Asset Turnover Ratio Statistics
High Average Low
14.07 8.43 5.87
(Sep 30 2023)   (Jun 30 2022)




CMRA Company Profile • Back to CMRA Efficiency Comparisons • Compare CMRA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Fresh Tracks Therapeutics Inc   0.89 $ 10.056  Millions$ 11.284  Millions
Stablecoin Development Corporation  0.87 $ 13.126  Millions$ 15.021  Millions
Lantheus Holdings Inc   0.87 $ 1,204.601  Millions$ 1,382.468  Millions
Inogen Inc   0.87 $ 327.855  Millions$ 377.191  Millions
National Healthcare Corp  0.87 $ 1,105.183  Millions$ 1,275.849  Millions
Pediatrix Medical Group Inc   0.87 $ 2,012.041  Millions$ 2,324.947  Millions
Waters Corporation  0.86 $ 2,995.452  Millions$ 3,465.118  Millions
Select Medical Holdings Corp  0.86 $ 6,586.658  Millions$ 7,687.727  Millions
Protalix Biotherapeutics inc   0.85 $ 63.625  Millions$ 74.583  Millions
Apyx Medical Corp  0.85 $ 49.010  Millions$ 57.609  Millions
Catalyst Pharmaceuticals Inc   0.85 $ 348.393  Millions$ 409.991  Millions
Community Health Systems Inc   0.85 $ 12,450.000  Millions$ 14,653.500  Millions
Marpai Inc  0.84 $ 36.077  Millions$ 42.878  Millions
Lakeland Industries Inc   0.84 $ 122.446  Millions$ 145.793  Millions
Orthofix Medical Inc   0.84 $ 667.747  Millions$ 795.676  Millions
Bgm Group Ltd  0.84 $ 45.751  Millions$ 54.575  Millions
Lite Strategy Inc   0.84 $ 105.383  Millions$ 125.962  Millions
Cardio Diagnostics Holdings Inc   0.83 $ 5.700  Millions$ 6.880  Millions
Reshape Lifesciences Inc  0.83 $ 9.746  Millions$ 11.793  Millions
Milestone Scientific Inc   0.82 $ 9.788  Millions$ 11.928  Millions
Aquestive Therapeutics Inc   0.82 $ 48.059  Millions$ 58.699  Millions
Sonoma Pharmaceuticals Inc   0.81 $ 12.116  Millions$ 14.922  Millions
Aspira Women s Health inc   0.81 $ 9.177  Millions$ 11.313  Millions
Tg Therapeutics Inc   0.81 $ 189.773  Millions$ 235.713  Millions
Cardiff Lexington Corporation  0.79 $ 12.348  Millions$ 15.553  Millions
West Pharmaceutical Services Inc   0.79 $ 2,926.400  Millions$ 3,691.175  Millions
Tandem Diabetes Care Inc   0.79 $ 771.241  Millions$ 973.379  Millions
Axogen inc   0.79 $ 152.254  Millions$ 192.783  Millions
Harvard Bioscience Inc   0.78 $ 111.802  Millions$ 143.393  Millions
Corcept Therapeutics Inc  0.78 $ 450.026  Millions$ 579.981  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.